======= CISH =======
== Gene Information ==
* **Official Symbol**: CISH
* **Official Name**: cytokine inducible SH2 containing protein
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1154|1154]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NSE2|Q9NSE2]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CISH&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CISH|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/602441|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene contains a SH2 domain and a SOCS box domain. The protein thus belongs to the cytokine-induced STAT inhibitor (CIS), also known as suppressor of cytokine signaling (SOCS) or STAT-induced STAT inhibitor (SSI), protein family. CIS family members are known to be cytokine-inducible negative regulators of cytokine signaling. The expression of this gene can be induced by IL2, IL3, GM-CSF and EPO in hematopoietic cells. Proteasome-mediated degradation of this protein has been shown to be involved in the inactivation of the erythropoietin receptor. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008].
* **UniProt Summary**: SOCS family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. CIS is involved in the negative regulation of cytokines that signal through the JAK-STAT5 pathway such as erythropoietin, prolactin and interleukin 3 (IL3) receptor. Inhibits STAT5 trans-activation by suppressing its tyrosine phosphorylation. May be a substrate- recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS- box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (By similarity). {ECO:0000250}.
|SH2|
|SOCS box|
|1-phosphatidylinositol-3-kinase regulator activity|
|interleukin-7-mediated signaling pathway|
|phosphatidylinositol 3-kinase complex|
|protein kinase C-activating G protein-coupled receptor signaling pathway|
|cellular response to interleukin-7|
|response to interleukin-7|
|negative regulation of insulin receptor signaling pathway|
|negative regulation of cellular response to insulin stimulus|
|phosphatidylinositol phosphorylation|
|regulation of phosphatidylinositol 3-kinase activity|
|regulation of lipid kinase activity|
|regulation of insulin receptor signaling pathway|
|lipid phosphorylation|
|regulation of cellular response to insulin stimulus|
|regulation of phospholipid metabolic process|
|phosphatidylinositol metabolic process|
|lipid modification|
|glycerophospholipid metabolic process|
|post-translational protein modification|
|phospholipid metabolic process|
|glycerolipid metabolic process|
|regulation of lipid metabolic process|
|regulation of cell growth|
|cellular component|
|regulation of growth|
|cytokine-mediated signaling pathway|
|protein ubiquitination|
|molecular function|
|protein modification by small protein conjugation|
|regulation of kinase activity|
|organophosphate metabolic process|
|cellular lipid metabolic process|
|regulation of transferase activity|
|protein modification by small protein conjugation or removal|
|cellular response to cytokine stimulus|
|response to cytokine|
|lipid metabolic process|
|negative regulation of signal transduction|
|phosphorylation|
|G protein-coupled receptor signaling pathway|
|negative regulation of cell communication|
|negative regulation of signaling|
|regulation of phosphorylation|
|negative regulation of response to stimulus|
|intracellular signal transduction|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|2.07|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 6716
* **Expression level (log2 read counts)**: 2.46
{{:chemogenomics:nalm6 dist.png?nolink |}}